Tapewire

Nasdaq · USD

VANI

Vivani Medical, Inc.

Export transactions ↓
Tapewire entity
6636
SEC CIK
0001266806
Parsed reports
325

Last 12 months

Inside the activity.

16 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202520
Dec 202530
Jan 202630
Feb 202620
Mar 202620
Apr 202610
May 202610
Jun 202610
Jul 202610
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 27, 2023 Filed Sep 27, 2023 23:53 UTC
Dwyer DonaldChief Business Officer
PurchaseCommon Stock 1,000 $1.01 $1,010.00
Disclosure

SEC source: 0001753926-23-001275 · ownership.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

F1 · kind: Individual purchased shares on the open market.

Read SEC document
September 26, 2023 Filed Sep 27, 2023 23:51 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 1,567 $0.94 $1,472.98
Disclosure

SEC source: 0001753926-23-001273 · ownership.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,307

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 25, 2023 Filed Sep 27, 2023 23:51 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 24,088 $0.95 $22,883.60
Disclosure

SEC source: 0001753926-23-001273 · ownership.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,740

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 21, 2023 Filed Sep 23, 2023 00:34 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 398 $0.93 $370.14
Disclosure

SEC source: 0001753926-23-001254 · ownership.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,652

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 20, 2023 Filed Sep 23, 2023 00:34 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 21,028 $0.92 $19,345.76
Disclosure

SEC source: 0001753926-23-001254 · ownership.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,254

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 18, 2023 Filed Sep 18, 2023 23:46 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 66,743 $0.96 $64,073.28
Disclosure

SEC source: 0001753926-23-001243 · ownership.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,226

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 23:46 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 35,036 $0.95 $33,284.20
Disclosure

SEC source: 0001753926-23-001243 · ownership.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,483

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 12, 2023 Filed Sep 13, 2023 01:12 UTC PurchaseCommon Stock 5,145 $0.96 $4,939.20
Disclosure

SEC source: 0001753926-23-001215 · ownership.xml · nonDerivative · entry 3

Williams Gregg · CIK 0001624919 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,447

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 11, 2023 Filed Sep 13, 2023 01:12 UTC PurchaseCommon Stock 1,854 $0.95 $1,761.30
Disclosure

SEC source: 0001753926-23-001215 · ownership.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,302

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:12 UTC PurchaseCommon Stock 6,998 $0.94 $6,578.12
Disclosure

SEC source: 0001753926-23-001215 · ownership.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,448

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 07, 2023 Filed Sep 7, 2023 22:17 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 33,700 $0.94 $31,678.00
Disclosure

SEC source: 0001753926-23-001198 · ownership.xml · nonDerivative · entry 3

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,450

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 06, 2023 Filed Sep 7, 2023 22:17 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 14,570 $0.94 $13,695.80
Disclosure

SEC source: 0001753926-23-001198 · ownership.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,750

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 05, 2023 Filed Sep 7, 2023 22:17 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 4,997 $0.93 $4,647.21
Disclosure

SEC source: 0001753926-23-001198 · ownership.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,180

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 01, 2023 Filed Sep 2, 2023 01:24 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 10,888 $0.94 $10,234.72
Disclosure

SEC source: 0001753926-23-001183 · ownership.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,183

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
September 01, 2023 Filed Sep 5, 2023 23:04 UTC PurchaseCommon Stock 4,000 $0.95 $3,780.00
Disclosure

SEC source: 0001753926-23-001190 · ownership.xml · nonDerivative · entry 2

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
August 31, 2023 Filed Sep 2, 2023 01:24 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 5,295 $0.92 $4,871.40
Disclosure

SEC source: 0001753926-23-001183 · ownership.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,295

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
August 31, 2023 Filed Sep 5, 2023 23:06 UTC
Dwyer DonaldChief Business Officer
PurchaseCommon Stock 7,500 $0.94 $7,050.00
Disclosure

SEC source: 0001753926-23-001192 · ownership.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · kind: Individual purchased shares on the open market.

Read SEC document
August 31, 2023 Filed Sep 5, 2023 23:04 UTC PurchaseCommon Stock 2,000 $0.90 $1,800.00
Disclosure

SEC source: 0001753926-23-001190 · ownership.xml · nonDerivative · entry 1

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
August 17, 2023 Filed Aug 18, 2023 18:43 UTC
Dwyer DonaldChief Business Officer
PurchaseCommon Stock 7,500 $1.08 $8,100.00
Disclosure

SEC source: 0001753926-23-001082 · ownership.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

F1 · kind: Individual purchased shares on the open market.

Read SEC document
June 28, 2023 Filed Jun 29, 2023 16:43 UTC PurchaseCommon Stock 3,000 $1.21 $3,630.00
Disclosure

SEC source: 0001753926-23-000869 · ownership.xml · nonDerivative · entry 2

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
June 27, 2023 Filed Jun 29, 2023 16:43 UTC PurchaseCommon Stock 1,000 $1.24 $1,240.00
Disclosure

SEC source: 0001753926-23-000869 · ownership.xml · nonDerivative · entry 1

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 15:03 UTC
Dwyer DonaldChief Business Officer
PurchaseCommon Stock 5,000 $1.24 $6,200.00
Disclosure

SEC source: 0001753926-23-000850 · ownership.xml · nonDerivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · kind: Individual purchased shares on the open market.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 19:27 UTC GrantCommon Stock Option · Derivative 32,121 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001753926-23-000811 · form_4.xml · derivative · entry 1

Baker Wilford Dean · CIK 0001377879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,121

Underlying: Common Stock · 32,121 shares

Expires 2033-06-15

F2 · derivative.exercise_date: Options vest monthly over a one-year period

F1 · balance_after: Awarded as compensation for serving on the Board of Directors.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 23:33 UTC
Williams GreggDirector · 10% owner
GrantCommon Stock Option · Derivative 32,121 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001753926-23-000817 · form_4.xml · derivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,121

Underlying: Common Stock · 32,121 shares

Expires 2033-06-15

F2 · derivative.exercise_date: Options vest monthly over a one-year period.

F1 · balance_after: Awarded as compensation for serving on The Board of Directors and its committees.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 23:31 UTC GrantCommon Stock Option · Derivative 32,121 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001753926-23-000815 · form_4.xml · derivative · entry 1

Mendelsohn Aaron · CIK 0001625195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,121

Underlying: Common Stock · 32,121 shares

Expires 2033-06-15

F2 · derivative.exercise_date: Options vest monthly over a one-year period.

F1 · balance_after: Awarded as compensation for serving on the Board of Directors.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 23:29 UTC GrantCommon Stock Option · Derivative 32,121 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001753926-23-000813 · form_4.xml · derivative · entry 1

Larson Alexandra L.P. · CIK 0001858534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,121

Underlying: Common Stock · 32,121 shares

Expires 2033-06-15

F2 · derivative.exercise_date: Options vest monthly over a one-year period.

F1 · balance_after: Awarded as compensation for serving on the Board of Directors.

Read SEC document
June 09, 2023 Filed Jun 13, 2023 01:32 UTC PurchaseCommon Stock 10,000 $1.30 $12,980.00
Disclosure

SEC source: 0001753926-23-000794 · form_4.xml · nonDerivative · entry 1

Mendelsohn Aaron · CIK 0001625195 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,170

F1 · ownership.direct: Represents shares of common stock purchased by Mr. Mendelsohn on the open market.

Read SEC document
April 28, 2023 Filed May 1, 2023 21:00 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 1,632,330 $1.10 $1,795,563.00
Disclosure

SEC source: 0001753926-23-000563 · ownership.xml · nonDerivative · entry 2

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 13,677,308

F2 · price: These shares were purchased from a private party at a price of $1.10 per share on April 28, 2023.

F3 · ownership.nature: Includes (i) 11,551,556 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Greg Williams has voting and dispositive power over all of these shares.

Read SEC document
April 27, 2023 Filed May 1, 2023 21:00 UTC
Williams GreggDirector · 10% owner
PurchaseCommon Stock 408,164 $0.98 $400,000.72
Disclosure

SEC source: 0001753926-23-000563 · ownership.xml · nonDerivative · entry 1

Williams Gregg · CIK 0001624919 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 12,044,978

F1 · price: These shares were purchased from a private party at a price of $0.98 per share on April 27, 2023

F3 · ownership.nature: Includes (i) 11,551,556 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Greg Williams has voting and dispositive power over all of these shares.

Read SEC document
April 18, 2023 Filed Apr 19, 2023 23:11 UTC GrantCommon Stock 1,967 $1.05 $2,065.35
Disclosure

SEC source: 0001753926-23-000483 · ownership.xml · nonDerivative · entry 2

Larson Alexandra L.P. · CIK 0001858534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,166

F1 · price: Shares acquired in open market transaction

Read SEC document
April 17, 2023 Filed Apr 19, 2023 23:11 UTC GrantCommon Stock 33 $1.05 $34.65
Disclosure

SEC source: 0001753926-23-000483 · ownership.xml · nonDerivative · entry 1

Larson Alexandra L.P. · CIK 0001858534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199

F1 · price: Shares acquired in open market transaction

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:32 UTC
Mendelsohn AdamDirector · CEO
GrantRSU · Derivative 100,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000259 · ownership.xml · derivative · entry 2

Mendelsohn Adam · CIK 0001940008 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F3 · shares: First third of RSUs vest when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after the second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:32 UTC
Mendelsohn AdamDirector · CEO
GrantCommon Stock Option · Derivative 200,000 $0.00 Strike: $1.09 $0.00
Disclosure

SEC source: 0001753926-23-000259 · ownership.xml · derivative · entry 1

Mendelsohn Adam · CIK 0001940008 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-03-06

F2 · shares: The stock options have a 10-year term and vest immediately when share price closes at $6.30 for three consecutive business days. If the options fail to reach $6.30 for three consecutive business days within a four year term from the date of grant the options expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:36 UTC
Dwyer DonaldChief Business Officer
GrantRSUs · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000267 · ownership.xml · derivative · entry 2

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:36 UTC
Dwyer DonaldChief Business Officer
GrantRSUs · Derivative 35,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000267 · ownership.xml · derivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:35 UTC GrantRSUs · Derivative 80,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000265 · ownership.xml · derivative · entry 1

Le Truc · CIK 0001940176 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:34 UTC
Porter Lisa EllenChief Medical Officer
GrantRSUs · Derivative 40,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000263 · ownership.xml · derivative · entry 2

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:34 UTC
Porter Lisa EllenChief Medical Officer
GrantRSUs · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000263 · ownership.xml · derivative · entry 1

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:33 UTC GrantRSUs · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000261 · ownership.xml · derivative · entry 2

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 02:33 UTC GrantRSUs · Derivative 37,500 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000261 · ownership.xml · derivative · entry 1

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2027-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock.

F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:42 UTC
Mendelsohn AdamDirector · CEO
GiftCommon Stock 17,000 $0.00 $0.00
Disclosure

SEC source: 0001753926-23-000124 · ownership.xml · nonDerivative · entry 1

Mendelsohn Adam · CIK 0001940008 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,605,015

F1 · kind: Represents shares of common stock gifted to a non-family member.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:13 UTC
Mendelsohn AdamDirector · CEO
GrantCommon Stock Option · Derivative 200,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000082 · ownership.xml · derivative · entry 1

Mendelsohn Adam · CIK 0001940008 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-01-19

F1 · shares: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:11 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 75,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000080 · ownership.xml · derivative · entry 2

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one year and monthly for 36 months thereafter on a equal basis.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:11 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 75,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000080 · ownership.xml · derivative · entry 1

Makes Brigid · CIK 0001375927 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one year and monthly for 36 months thereafter on a equal basis.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:09 UTC
Dwyer DonaldChief Business Officer
GrantCommon Stock Option · Derivative 70,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000078 · ownership.xml · derivative · entry 2

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:09 UTC
Dwyer DonaldChief Business Officer
GrantCommon Stock Option · Derivative 30,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000078 · ownership.xml · derivative · entry 1

Dwyer Donald · CIK 0001940425 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:08 UTC
Porter Lisa EllenChief Medical Officer
GrantCommon Stock Option · Derivative 40,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000076 · ownership.xml · derivative · entry 2

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:08 UTC
Porter Lisa EllenChief Medical Officer
GrantCommon Stock Option · Derivative 80,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000076 · ownership.xml · derivative · entry 1

Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis.

Read SEC document
January 19, 2023 Filed Jan 24, 2023 02:06 UTC GrantCommon Stock Option · Derivative 160,000 $0.00 Strike: $1.27 $0.00
Disclosure

SEC source: 0001753926-23-000074 · ownership.xml · derivative · entry 1

Le Truc · CIK 0001940176 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis.

Read SEC document
January 03, 2023 Filed Apr 25, 2023 21:50 UTC PurchaseCommon Stock 10,000 $0.90 $9,000.00
Disclosure

SEC source: 0001753926-23-000518 · ownership.xml · nonDerivative · entry 3

Bolck Joachim Eberhard · CIK 0001974849 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,524,229

F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.